S&P 500 Industrials Sector SEC Filings — April 14, 2026

14-04-2026

Regent Peak Wealth Advisors LLC filed a 13F-HR report on April 14, 2026, disclosing total holdings of $490,319,320 across 198 positions as of March 31, 2026. The portfolio is diversified with top holdings including Apple Inc. ($27,373,382, 107,858 shares), Vanguard Total Bond Market ETF ($24,768,437, 336,345 shares), and Nvidia Corporation ($15,459,178, 88,642 shares). All reported positions have sole voting authority, with no period-over-period changes disclosed in the filing.

• ·Filing period end date: 2026-03-31
• ·All holdings reported as sole discretionary voting authority (SH SOLE)

14-04-2026

Ms. Joyce J. Lee, a Class II Director of Phibro Animal Health Corporation, informed the company on April 13, 2026, of her intention to resign from the Board effective April 15, 2026. The resignation was not due to any disagreement with the company's operations, policies, or practices. No other material details or impacts were disclosed.

14-04-2026

Antalpha Platform Holding Co's 20-F for year ended December 31, 2025 reports net cash used in operating activities improving significantly to $(3,838) thousand from $(11,694) thousand in 2024, while net cash used in investing activities also decreased sharply to $(6,856) thousand from $(76,171) thousand. However, net cash from financing activities dropped 86% YoY to $12,630 thousand from $93,353 thousand, leading to a lower net increase in cash of $1,924 thousand versus $5,488 thousand prior year. Crypto assets received as revenue grew modestly 3% YoY to $48,207,213 thousand, amid substantial related-party loans, collateral movements, and diversification into XAUt.

• ·Post-Reorganization, dedicated clearing account established for margin loan transactions as agent.
• ·Pre-Reorganization shared accounts led to unrelated fund flows between customers and related parties.
• ·Temporary crypto fund support from related party during Antalpha Prime initial setup, settled in ordinary course.
• ·Options exercise price: Nominal for all listed grants.
• ·Total Class A Ordinary Shares options for other employees/consultants exceed 1.7M across multiple grants.

14-04-2026

REGENXBIO Inc.'s DEF 14A Proxy Statement for the May 29, 2026 Annual Meeting seeks stockholder approval to elect three Class II directors (Jean Bennett, A.N. 'Jerry' Karabelas, and Daniel Tassé), ratify PricewaterhouseCoopers LLP as auditors for 2026, approve an advisory vote on executive compensation, and authorize stock option exchanges for non-executive and executive employees to replace underwater options. 2025 business highlights include clinical progress in ABBV-RGX-314 and RGX-202 programs, a $110.0 million upfront payment from Nippon Shinyaku, $150 million from a royalty bond (up to $250 million), AbbVie milestone amendments worth $200 million, and $240.9 million in cash at year-end; however, the RGX-121 program encountered an FDA clinical hold in January 2026 and a Complete Response Letter in February 2026.

• ·Record date for Annual Meeting: April 1, 2026
• ·FDA priority review for RGX-121 BLA granted May 2025 with initial PDUFA date November 9, 2025 (revised to February 8, 2026)
• ·FDA clinical hold on RGX-121 program in January 2026 due to serious adverse event in RGX-111 trial
• ·Board nominees to serve until 2029 annual meeting
• ·Engaged with top 25 stockholders representing 68% of outstanding common stock in 2025

14-04-2026

Bank of Finland filed a 13F-HR report on April 14, 2026, disclosing its holdings as of March 31, 2026, in four ETFs with a total market value of $1,366,372,990. The largest holding is DBX ETF TR XTRACKERS MSCI valued at $422,341,035 (10,822,209 shares), followed by ISHARES TR CORE S&P500 ETF at $342,000,506 (523,569 shares). No changes in holdings or performance metrics were reported in this quarterly snapshot.

• ·CUSIP for ISHARES TR CORE MSCI INTL: 46435G326
• ·CUSIP for ISHARES TR CORE S&P500 ETF: 464287200
• ·CUSIP for ISHARES TR PARIS ALIGNED CL: 46436E411
• ·CUSIP for DBX ETF TR XTRACKERS MSCI: 23306X605
• ·All holdings reported as sole ownership with full voting authority

14-04-2026

Brookfield Asset Management Ltd. filed an 8-K on April 14, 2026, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), announcing the issuance of a press release dated April 14, 2026, attached as Exhibit 99.1. The filing contains no financial data, performance metrics, or specific details from the press release. It was signed by Kathy Sarpash, Managing Director, Legal & Regulatory and Corporate Secretary.

14-04-2026

ImmuCell Corporation (Nasdaq: ICCC) appointed Dr. Gilles Guillemette and Dr. Anthony DiMarco to its Board of Directors effective April 15, 2026, to bolster its innovation strategy in animal health biologics, particularly for the First Defense® product line. The company is transitioning to a 7-person Board with six independent directors and the CEO, establishing a new Strategy and Technology Committee chaired by Dr. Guillemette. Retiring board members Bryan Gathagan, Michael Brigham, and Bobbi Brockmann step down effective April 15, 2026, while Timothy Fiori retires after the June 11, 2026 Annual Meeting.

• ·Annual Meeting of Stockholders scheduled for June 11, 2026 at 9:30 AM ET via live audio webcast and telephone.
• ·Ms. Brockmann and Mr. Fiori will continue in their executive roles post-retirement from the Board.
• ·Updated Investor Presentation available at http://www.immucell.com/investors.

14-04-2026

Serve Robotics Inc. completed its acquisition of Diligent Robotics, Inc. on January 27, 2026, via a merger agreement dated January 19, 2026. This 8-K/A amendment provides Diligent's audited 2025 financials, which show revenue of $9,044 thousand but a gross loss of $1,385 thousand due to cost of revenues exceeding revenue, alongside a net loss of $22,708 thousand driven by high operating expenses of $18,936 thousand. Diligent reported total assets of $13,436 thousand but carried a stockholders' deficit of $110,240 thousand and significant current liabilities of $17,285 thousand exceeding current assets.

• ·Diligent's operating expenses breakdown: General and administrative $5,653 thousand, Operations $2,811 thousand, Research and development $6,789 thousand, Sales and marketing $3,683 thousand.
• ·Other expenses include interest expense net $1,319 thousand, loss on extinguishment of SVB Loans $74 thousand, loss on issuance of Bridge Loans $1,100 thousand ($600 thousand to related parties).
• ·Auditor consent from dbbmckennon dated April 13, 2026.
• ·Pro forma condensed combined financial statements of Serve as of December 31, 2025 filed as Exhibit 99.2.

14-04-2026

Runnymede Capital Advisors, Inc. filed its 13F-HR report for the quarter ended March 31, 2026, disclosing a total portfolio value of $116.4 billion across 75 holdings, heavily concentrated in technology and leveraged ETFs. Top positions include ProShares Ultra Technology UIT Exchange Traded ($11.97B), Invesco QQQ TR UIT Exchange Traded ($7.82B), NVIDIA Corp ($7.15B), Alphabet Inc ($6.70B), and Amazon.com Inc ($6.68B). The portfolio also features significant allocations to Apple ($6.26B), Microsoft ($5.65B), and crypto-related ETFs like Grayscale Bitcoin Trust ($639M).

• ·Filing date: April 14, 2026
• ·Report period end date: March 31, 2026
• ·All positions reported as sole ownership with no shared or other voting authority

14-04-2026

XCF Global, Inc. (SAFX) entered into a definitive Business Combination Agreement on April 13, 2026, with DevvStream Corp. and Southern Energy Renewables Inc., structured as mergers where both targets will become wholly-owned subsidiaries in exchange for Company Common Shares, following a prior term sheet from January 26, 2026. The deal advances strategic growth in renewables but remains subject to extensive closing conditions including shareholder approvals, regulatory clearances, fairness opinions, $400M Louisiana bond issuance approval, $10M minimum cash, $1B annualized revenue target by June 30, 2026, and execution of key offtake agreements. Termination fees range from $510,000 to $1.19M apply in certain scenarios, with an Outside Date approximately 10 months from signing.

• ·Fairness opinions required within 20 Business Days of BCA signing, with termination rights if not received.
• ·Outside Date is 10 months from April 13, 2026, with possible 30-day extension.
• ·Southern shareholder approval already obtained prior to BCA execution.
• ·DevvStream equity awards (warrants, options, RSUs, convertible notes) to convert into Company Common Shares.

14-04-2026

DevvStream Corp. entered into a definitive Business Combination Agreement on April 13, 2026, with XCF Global, Inc. and Southern Energy Renewables Inc., structuring mergers where DevvStream (post-domestication to Delaware) and Southern become wholly-owned subsidiaries of XCF, subject to shareholder approvals, regulatory clearances, and fairness opinions. Key conditions include Southern securing approval for at least $400,000,000 in Louisiana bonds, $10,000,000 in cash/funding, SAF and European Offtake Agreements, and XCF achieving over $1,000,000,000 annualized revenue and $100,000,000 EBITDA by June 30, 2026, with termination fees of $510,000 and potential expense reimbursements up to $170,000 highlighting execution risks. The deal advances prior term sheet terms but faces substantial closing hurdles and no assurances of completion.

• ·Outside Date: 10 months from BCA date (April 13, 2026), extendable by 30 days by mutual agreement
• ·Fairness opinions (Company and XCF) required within 20 Business Days of BCA, non-delivery allows termination
• ·Southern Shareholders pre-approved the Mergers, so their approval not a closing condition
• ·Company equity awards (Warrants, Options, RSUs, Convertible Notes) to convert into XCF equivalents

14-04-2026

Unity Bancorp reported Q1 2026 net income of $14.3 million ($1.40 per diluted share), down 7.7% QoQ from $15.5 million ($1.52) due to lower net interest income ($30.7 million, -2.0%) and noninterest income ($2.9 million, -25.6%), though up 23.2% YoY from $11.6 million amid 12.8% YoY NII growth. Balance sheet showed growth with gross loans up 2.2% QoQ ($2,601.7 million) and 10.9% YoY, deposits up 2.4% QoQ ($2,379.1 million), and shareholders' equity up 3.6% to $358.1 million, while noninterest expense rose 6.0% QoQ to $14.1 million. Capital ratios improved slightly QoQ, nonaccrual assets ticked up 2.5% to $32.1 million, and the company announced a 7% dividend increase to $0.16 per share.

• ·Provision for credit losses decreased 52.8% QoQ to $1.0 million.
• ·Uninsured/uncollateralized deposits at 21.6% of total deposits as of March 31, 2026.
• ·Named one of Piper Sandler’s Top Bank Investment Ideas for 2026.
• ·Annual shareholder meeting scheduled for April 23, 2026 at 8:00 AM EDT.
• ·Total assets $3.0 billion, with $229.2 million cash and cash equivalents.

14-04-2026

Day One Biopharmaceuticals, Inc. filed Amendment No. 2 to its Schedule 14D-9, updating sections of Centerview Partners LLC's fairness opinion, including selected public company analysis (implied equity value per share of $11.80-$20.00), precedent transactions ($17.25-$25.40 per share), and detailed unaudited prospective financial projections showing net revenue growing from $261M in 2026E to a peak of $1,131M in 2035E before declining to $214M in 2044E. The amendments support the $21.50 per share cash tender offer by Servier Detroit Inc. pursuant to the March 6, 2026 Merger Agreement; however, new disclosures reveal stockholder litigation alleging disclosure deficiencies in the initial Schedule 14D-9.

• ·Selected public company EV/2029E Revenue Multiples ranged from 1.1x (Geron) to 3.5x (Arcutis).
• ·Precedent transaction TV/4-Year Forward Revenue Multiples ranged from 1.7x to 5.2x (median 2.6x); reference range applied was 2.5x-4.0x.
• ·DCF analysis used discount rates of 12.5%-15.5% and projected unlevered free cash flows through 2044.
• ·Projected net revenues peak at $1,131M in 2035E then decline (e.g., $800M in 2036E, $214M in 2044E).
• ·Stockholder lawsuits filed March 31, 2026 (Lawrence v. Day One) and April 1, 2026 (Kent), seeking injunction, revisions to Schedule 14D-9, and damages.

14-04-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on April 14, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Exhibits), announcing the issuance of a press release titled 'AITX Takes Next Step in Market Structure Evolution with OTCQB Application.' The press release is furnished as Exhibit 99.1. The filing was signed by CEO Steven Reinharz.

• ·Filing Date: April 14, 2026
• ·Date of Earliest Event Reported: April 14, 2026
• ·Principal Executive Offices: 10800 Galaxie Avenue, Ferndale, Michigan, United States 48220
• ·Telephone: (877) 787-6268
• ·State of Incorporation: Nevada
• ·Commission File Number: 000-55079
• ·IRS Employer Identification No.: 27-2343603

14-04-2026

Drive Wealth Management, LLC filed its 13F-HR combination report on April 14, 2026, disclosing equity holdings as of March 31, 2026, including positions managed in conjunction with Towrsquare Capital LLC, Parametric Portfolio Associates LLC, and AQR Capital Management LLC. Notable holdings include large ETF positions such as Capital Group Fixed Income ETF (188,121 shares) and iShares AAA CLO ETF (174,773 shares), alongside individual stocks like Apple Inc. (10,260 shares), Comcast Corp (18,168 shares), and Exxon Mobil Corp (15,751 shares). No total portfolio value, performance metrics, or period-over-period changes are provided in the filing.

• ·Report period end date: March 31, 2026
• ·Business address: 3333 N Digital Drive #700, Lehi, UT 84043
• ·All reported positions held with sole voting and disposition power
• ·Partial list of holdings provided; filing includes ETFs, stocks across sectors

14-04-2026

urban-gro, Inc. entered into a Securities Purchase Agreement dated April 7, 2026, with Agile Hudson Partners LLC for an initial $500,000 First Tranche funding under a convertible Note and accompanying Warrants, exempt from registration under Section 4(a)(2) of the 1933 Act and Rule 506(b). A conditional Second Tranche of $500,000 may follow within 10 trading days of satisfying conditions including the filing of the 10-K for the period ended December 31, 2025, at which point the Note's principal would increase by $549,504.95 (including OID) and accrued interest by $65,940.60. As of April 7, 2026, the Company had 875,600 shares of Common Stock issued and outstanding out of 200,000,000 authorized shares.

• ·Buyer is an accredited investor purchasing Securities for investment, not resale.
• ·Second Tranche Funding Conditions include filing the 10-K with audited financials for fiscal years ended December 31, 2024 and 2025.
• ·Securities subject to restrictive legends until registered or exempt sale under Rule 144, Rule 144A, or Regulation S.

14-04-2026

Stonebridge Capital Management Inc, based in Los Angeles, CA, filed its quarterly 13F-HR on April 14, 2026, disclosing equity holdings as of March 31, 2026, with a total portfolio value of $219,915,188 across 80 positions, all held with sole discretionary voting authority. Top holdings include Apple Inc. ($17,952,618 for 70,738 shares), Microsoft Corp. ($16,089,454 for 43,465 shares), and Cisco Systems Inc. ($5,667,329 for 73,042 shares). No period-over-period changes are available in this filing.

• ·Business address: 1801 Century Park East Suite 1800, Los Angeles, CA 90067
• ·All positions reported as SH SOLE with 0 shared or other voting authority
• ·Includes mutual funds such as PRIMECAP ODYSSEY FUND (260,414 shares, $9,119,700) and Schwab funds

14-04-2026

AMERICAN BATTERY MATERIALS, INC. (BLTH) filed an S-1/A registration statement on April 14, 2026, as part of its IPO process, covering periods through 2025-12-31. The company disclosed significant material weaknesses in its internal control over financial reporting and disclosure controls, including insufficient qualified accounting personnel, lack of segregation of duties, and ineffective handling of complex transactions under U.S. GAAP. These issues raise risks of financial statement errors, potential restatements, and loss of investor confidence impacting stock price, with no offsetting positive financial metrics provided.

• ·Material weaknesses may lead to errors requiring restatements of consolidated financial statements.
• ·Multiple promissory notes, convertible notes, and related-party transactions referenced across 2023-2025 periods.
• ·XBRL tags indicate equity components (Preferred Stock, Common Stock, Additional Paid-In Capital, Retained Earnings) for periods ending 2023-12-31, 2024-12-31, and 2025-12-31.

14-04-2026

Colorado Capital Management, Inc. disclosed its 13F-HR holdings as of March 31, 2026, totaling $268.222 million across 106 positions, with a strong emphasis on Dimensional ETFs, NuShares ESG funds, iShares ESG products, and Vanguard index funds. Top holdings include DBX ETF TR XTRCKR MSCI US ($17.712M), Dimensional ETF Trust INTL CORE EQT MK ($16.543M), and Vanguard World FD MEGA CAP INDEX ($14.068M). The portfolio features no shared voting authority, all as sole discretionary.

• ·All 106 positions held with sole voting authority (SH SOLE); no shared or other authority reported.
• ·Heavy allocation to ESG/sustainable themes including NuShares ESG series ($24.1M+ across funds), iShares ESG products ($20M+), and Dimensional sustainability funds.
• ·Individual equities represent smaller portion, e.g., Apple Inc. 33299 shares ($8.451M), Alphabet Inc. Cl A 7174 shares ($2.063M).

14-04-2026

Alphega Innovations Corp reported a significantly widened net loss of $1,176,593 for the three months ended February 28, 2026, up 92% YoY from $613,208, driven by elevated expenses including consulting ($140,250), legal fees ($840,729), and a $144,666 loss on settlement, with no revenue generated. Total liabilities rose 46% QoQ to $3,261,023 as of February 28, 2026, mainly from a $887,148 increase in due to related parties to $2,768,740, deepening the stockholders' deficit to $(3,254,302). Cash balance improved modestly 225% QoQ to $6,721, supported by $40,000 in related party financing amid $35,349 cash used in operations.

• ·Basic and diluted weighted average shares outstanding: 14,749,666 (2026) vs 14,670,000 (2025)
• ·Common stock issued for services: $160,740 (adjustment in cash flow from operations, 2026)
• ·Short term business loan unchanged at $17,000 QoQ
• ·No cash flows from investing activities in either period
• ·Entity is a small business and emerging growth company per filing

14-04-2026

BayBridge Capital Group, LLC filed its 13F-HR on April 14, 2026, disclosing $161398213000 in total equity holdings across 95 positions as of March 31, 2026, all with sole voting and disposition power. Top holdings include iShares Core U.S. Aggregate Bond ETF ($26053065000), Vanguard Total Stock Market ETF ($9226008000), SPDR S&P 500 ETF Trust ($7150029000), iShares Core S&P Mid-Cap ETF ($6311025000), and NVIDIA Corporation ($3853600000). The portfolio shows heavy allocation to bond and broad market ETFs alongside technology stocks, with no quarter-over-quarter changes reported in this snapshot.

• ·All holdings reported with sole voting power (SH SOLE) and no shared power
• ·Filer CIK: 0001898297, based in Livermore, CA
• ·No put/call options or other investment discretion reported

14-04-2026

Apellis Pharmaceuticals' Board unanimously recommends stockholders tender shares in Biogen's tender offer, citing Biogen's financial strength, absence of financing conditions, and high likelihood of timely regulatory approvals and consummation. The deal provides upfront cash certainty plus CVRs tied to SYFOVRE® milestones, but risks include business disruptions, management distraction, taxable gains, and no full participation in Apellis' standalone growth potential. A $205,000,000 termination fee applies for superior proposals post-March 31, 2026.

• ·Projections prepared for 2026-2059 on standalone basis, provided to Board and Evercore for fairness opinion.
• ·Merger to be effected under Section 251(h) of the DGCL, no additional stockholder approval needed post-tender.
• ·Annual Report for fiscal year ended December 31, 2025 filed February 24, 2026.

14-04-2026

AgEagle Aerial Systems Inc. (dba EagleNXT) announced a $10.0 million strategic investment acquiring a stake in Israel’s ThirdEye Systems Ltd. and the launch of a U.S. joint venture, ThirdEye USA, LLC, where EagleNXT holds 51% ownership and appoints three of five managers. The JV, based in Allen, Texas, will produce counter-drone systems like Argus Shield and Meduza X for U.S. and Canadian markets, with operations expected by May 2026. This move expands EagleNXT’s defense offerings, complementing prior investments like Aerodrome Group Ltd., with no financial declines reported.

• ·ThirdEye USA to operate from EagleNXT’s headquarters in Allen, Texas
• ·Joint venture anticipated operational by May 2026
• ·EagleNXT entitled to appoint three of five managers in ThirdEye USA

14-04-2026

California Bancorp filed Definitive Additional Proxy Materials (DEFA14A) on April 14, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required. This supplements their proxy statement but contains no financial metrics, performance data, or material disclosures.

• ·Filing checkbox: Filed by the Registrant
• ·Payment of Filing Fee: No fee required

14-04-2026

On April 14, 2026, the Board of Directors of Ohio Valley Banc Corp. declared a quarterly cash dividend of $0.25 per common share. The dividend is payable on May 10, 2026 to shareholders of record on April 24, 2026. No comparative dividend amounts or performance metrics were provided in the filing.

• ·Trading symbol: OVBC on NASDAQ
• ·Filing under Item 8.01 Other Events

14-04-2026

Nova Wealth Management, Inc. filed a 13F-HR report disclosing total equity holdings of $153,542,097 across 545 positions as of March 31, 2026. The portfolio is diversified with a focus on ETFs and stocks, including top holdings such as Amazon.com Inc. ($1,260,717), iShares Morningstar Growth ETF ($167,09), and iShares Morningstar Mid-Cap Growth ETF ($805,581). No period-over-period changes are available in this filing.

• ·All reported holdings are under sole ownership/discretion.
• ·Filing submitted from Bonita Springs, FL.

14-04-2026

American State Bank (Iowa) filed a 13F-HR disclosing $149,054,402 in total holdings value across 122 positions as of March 31, 2024. Top holdings include NVIDIA Corporation ($10.9M), iShares Russell 1000 Growth ETF ($8.0M), Microsoft Corp ($5.8M), and Invesco QQQ Trust ($6.9M), with significant allocations to ETFs and blue-chip stocks. No period-over-period changes are provided in this snapshot filing.

• ·Holdings consist entirely of sole voting authority positions (no shared or other authority indicated).
• ·Significant ETF exposure including multiple iShares and SPDR funds.
• ·Filing covers period ending March 31, 2024, submitted April 14, 2026.

14-04-2026

The Federal Home Loan Bank of Chicago filed an 8-K disclosing consolidated obligation bonds and discount notes committed to be issued on trade dates April 8-10, 2026, for which it is the primary obligor, with total par value of $230 million and maturities ranging from October 2026 to April 2046. Instruments include fixed constant rate bonds at coupons of 4.000% to 5.500% and a variable single index floater, primarily with optional principal redemption features. This is routine disclosure of debt securities backed jointly by the eleven Federal Home Loan Banks, regulated by the FHFA.

• ·All listed consolidated obligations exclude discount notes with maturity of one year or less issued in ordinary course.
• ·Schedule A reports principal at par, which may differ from GAAP financial statement amounts due to discounts, premiums, or concessions.
• ·Consolidated obligations are joint and several obligations of the eleven Federal Home Loan Banks, not guaranteed by U.S. government.

14-04-2026

Northrim BanCorp, Inc. issued Definitive Additional Proxy Materials (DEFA14A) for its 2026 Annual Meeting of Shareholders, to be held virtually on May 28, 2026, at 9:00 AM Alaska Daylight Time. Shareholders will vote on Proposal 1: election of twelve director nominees; Proposal 2: first amendment to the 2025 Stock Incentive Plan to add non-employee directors; Proposal 3: non-binding advisory vote on named executive officer compensation; and Proposal 4: ratification of Baker Tilly US, LLP as independent auditors for fiscal year 2026, with the Board recommending a FOR vote on all proposals. Proxy materials and the 2025 Annual Report on Form 10-K are available online at www.proxyvote.com and www.northrim.com.

• ·Virtual meeting access: www.virtualshareholdermeeting.com/NRIM2026 (requires 16-digit Control Number)
• ·Fiscal year for 10-K: ended December 31, 2025
• ·Contact for hard copies: Corporate Secretary, P.O. Box 241489, Anchorage, AK 99524-1489; phone (907) 562-0062; fax (907) 562-1758

14-04-2026

Saga Communications Inc. reported net operating revenue of $107,112 thousand for the year ended December 31, 2025, down 5.1% from $112,919 thousand in 2024, with market contributions showing slight declines in Milwaukee (11% vs 12%) and Columbus (7% vs 8%) while others remained flat. Significant impairments of goodwill ($19,229 thousand) and intangible assets ($1,168 thousand) drove an operating loss of $11,044 thousand and net loss of $7,899 thousand (EPS -$1.22), compared to operating income of $2,355 thousand and net income of $3,460 thousand (EPS $0.55) in 2024. However, station operating expenses were nearly flat at $91,781 thousand (-0.1%), cash and equivalents rose to $22,506 thousand from $18,860 thousand, and dividends were reduced to $1.00 per share from $1.60.

• ·Milwaukee market contributed 11% of consolidated net operating revenue in 2025 (down from 12% in 2024)
• ·Goodwill fully impaired to $0 from $19,229 thousand as of Dec 31 2025
• ·Long-term debt steady at $5,000 thousand
• ·Dividends declared per share $1.00 in 2025 (down from $1.60 in 2024)

14-04-2026

Alpha Cognition Inc. entered into a settlement agreement with Galantos Pharma GmbH i.L. on April 10, 2026, agreeing to make a one-time payment of EUR 5,214,220 by April 15, 2026, in full satisfaction of all remaining royalty and milestone obligations under the 2013 Memogain Asset Purchase Agreement. The settlement provides an approximate 40% discount to the estimated market value of the remaining obligations based on management's assessment. Mutual releases extinguish future liabilities for both parties, with no further payments due.

• ·Galantos Pharma GmbH i.L. is in liquidation and winding up process.
• ·Approximately €5M of the settlement payment relates to royalty entitlements accrued during fiscal year 2025 for documentation purposes.
• ·Agreement includes mutual covenants not to sue, no disparagement, and confidentiality provisions.

14-04-2026

On April 8, 2026, Dennis Wolf resigned from the Board of Directors of Codexis, Inc., effective immediately, including his roles on the Audit Committee and Compensation Committee, with no disagreement on any matter relating to operations, policies, or practices. On April 10, 2026, to rebalance director classes, Esther Martinborough, Ph.D., resigned from Class II and was immediately re-elected to Class III, retaining uninterrupted service on the Compensation, Strategy, and Science & Technology Committees as Chair of the latter. Following the rebalance, the Board consists of three directors each in Class I, II, and III.

• ·Filing signed by Georgia Erbez on April 14, 2026.
• ·Securities: Common Stock, par value $0.0001 per share (CDXS, Nasdaq Global Select Market).

14-04-2026

Redwood Mortgage Investors IX's 10-K for year ended December 31, 2025 shows net income declining sharply to $1,825 from $3,388 in 2024, driven by lower interest income of $5,042 versus $6,818 and higher provision for credit losses at $335 versus $90, while total operations expense rose slightly to $2,918 from $2,719. However, secured loans principal grew to $58,163 from $53,475, with first trust deeds increasing to $49,788 principal from $46,945. Members’ capital gross fell to $61,788 from $65,995 amid $3,307 in redemptions and $2,485 distributions, and total assets decreased to $59,140 from $67,115.

• ·Provision for credit losses increased to $335 in 2025 from $90 in 2024.
• ·Line of credit balance reduced to $0 from $4,000.
• ·Cash balance dropped to $562 from $12,058.
• ·Member redemptions slightly decreased to $3,307 from $3,458.

14-04-2026

Precedent Wealth Partners, LLC filed its 13F-HR on April 14, 2026, disclosing equity holdings as of March 31, 2026, with a total portfolio value of $499,602,170 across 166 positions, all held on a sole discretionary basis. The portfolio is heavily weighted toward ETFs such as Vanguard Tax-Managed Funds FTSE Developed Markets ETF (valued at $32,486,541 for 506,968 shares) and First Trust Exchange-Traded Fund SMID Rising ETF (valued at $11,563,107 for 293,256 shares), alongside individual stocks like Apple Inc. ($6,033,391 for 23,773 shares) and Microsoft Corp. ($3,912,719 for 10,570 shares). No prior period data is provided for comparison, and all positions reflect current holdings without noted changes.

• ·Filing covers period ending 03-31-2026
• ·All 166 holdings are SH SOLE with 0 shared, 0 other manager, 0 performance row
• ·Address: 1800 West Loop South, Suite 1400, Houston, TX 77027
• ·Phone: (713) 244-6450

14-04-2026

For the year ended December 31, 2025, Heritage Distilling Holding Company, Inc. reported total net revenues of $10,119,387, up 20.4% YoY from $8,402,488, driven by new Crypto and Related segment revenue of $4,951,565; however, Spirits Products revenues declined 36.5% YoY to $4,198,887 and Spirits Services fell 45.7% YoY to $968,935. Gross profit more than doubled to $5,560,090, but operating expenses surged to $139,504,521 primarily due to a $118,199,949 change in fair value of intangible digital assets and $3,392,744 in restructure costs, resulting in an operating loss of $133,944,431 and net loss of $137,715,315 versus a prior-year net income of $710,458.

• ·Basic EPS: $(16.03) in 2025 vs $0.98 in 2024.
• ·Diluted EPS: $(16.03) in 2025 vs $(39.46) in 2024.
• ·Weighted Average Common Shares Outstanding, Basic: 8,619,951 in 2025 (up significantly from 64,066 in 2024).
• ·Crypto Gross Margin: 95.3% overall in 2025.

14-04-2026

On April 14, 2026, Addentax Group Corp. received written notice from Nasdaq confirming it regained compliance with Listing Rule 5550(a)(2), as the closing bid price of its common stock was $1.00 per share or greater for 10 consecutive business days from March 30 through April 13, 2026. Nasdaq stated that this compliance matter is now closed, resolving prior listing concerns.

• ·Nasdaq Listing Rule 5550(a)(2) compliance regained based on 10 consecutive business days of $1.00+ closing bid price.
• ·Item 9.01 includes Exhibit 104: Cover Page Interactive Data File.

14-04-2026

Bayview Acquisition Corp held its annual general meeting on April 10, 2026, with 2,274,294 shares present, representing 83.05% quorum of the 2,738,292 shares entitled to vote as of the March 2, 2026 record date. John Joseph DeVito was re-elected as Class I director for a three-year term with 2,184,194 FOR votes (79.76%) and 90,100 abstentions (3.29%), with no votes against. The ratification of UHY LLP as independent auditor for the fiscal year ending December 31, 2026 received unanimous approval from all votes cast.

• ·Record date for Annual Meeting: March 2, 2026
• ·Proxy statement filed with SEC: March 23, 2026
• ·No broker non-votes for auditor ratification

14-04-2026

Invesco Mortgage Capital Inc. announced Kevin Collins, current President, will become Chief Executive Officer effective May 1, 2026, succeeding John Anzalone who is retiring after a nine-year tenure as CEO. David Lyle, current Chief Operating Officer, will assume the role of President on the same date. The leadership transition emphasizes continuity with experienced executives, alongside recent shift to monthly dividend distributions to enhance investor alignment.

• ·John Anzalone to remain in advisory role through October 1, 2026
• ·Kevin Collins involved in company formation in 2009 and President since 2017; Co-Head of Structured Investments for Invesco Fixed Income
• ·David Lyle COO since 2017, involved since 2009; over 20 years in securitized markets; Co-Head of Structured Investments for Invesco Fixed Income

14-04-2026

Murphy Pohlad Asset Management LLC filed its 13F-HR report on April 14, 2026, disclosing holdings as of March 31, 2026, with a total portfolio value of $278,977,471,000 across 134 positions, all held with sole voting authority. Top holdings by value include SLB Limited ($6,518,770,000), Medtronic PLC ($5,737,703,000), Intel Corp ($5,698,374,000), Chevron Corporation ($5,344,433,000), and VF Corp ($4,708,693,000). The diversified portfolio spans energy, healthcare, technology, financials, and ETFs with no reported options or shared voting authority.

• ·All 134 positions reported with sole voting authority and no put/call options.
• ·Significant ETF holdings include Dimensional ETF Trust US Core Equity 2 (22,504 shares, $874,505,000) and various Vanguard funds.
• ·Firm based in Eden Prairie, MN, with SEC file number 028-15160.